Study of Ticilimumab in Patients With Metastatic Colorectal Cancer Whose Disease Had Progressed After Treatment
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
This study is for patients with metastatic adenocarcinoma arising from the colon or rectum
who have received treatment(s) for metastatic disease with subsequent disease progression.
Patients who are intolerant to treatment(s) are also included. This is a study for good
performance status colorectal cancer patients who have exhausted standard therapy options.